Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO
The company is one of the most profitable companies manufacturing speciality chemicals in India
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Cipla and Ethris partner for the development of mRNA-based therapies
The new facility will be able to handle four times as many patients as the previous facility.
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Modi stressed the need to ensure that the entire Covid infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes, and human resources
Subscribe To Our Newsletter & Stay Updated